《大行報告》大摩相信萬洲(00288.HK)股價30月內將升 評級「增持」
摩根士丹利發表研究報告,指相信萬洲(00288.HK)股價會於未來30日上升,發生的機會率為70-80%,目標價看10元,評級「增持」。該行指,因近日股價有沽售壓力,令短期估值變得吸引,公司股價今年至今持平,而其中國附屬雙匯(000895.SZ)股價升17%,同時MSCI中國指數則跌2%。基於需求相對具韌性,因此市場有正面反應。不過,該行相信,美國及國際業務目前價值被低估,預期美國於去年第四季經營利潤增長為57%。雖然美國生豬肉價格於年初至今走低,但料增加出口至中國,第一季及第二季美國業務可帶來對沖作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.